研究目的
To present stimuli with varied sizes, colors, and patterns over a large range of luminance for optogenetics treatment of severe retinal degenerations and for gene therapy of cone diseases.
研究成果
The modified MP1 can be developed into an outcome measure for treatments in patients with severe retinal degeneration, very low vision, and abnormal eye movements, as well as for patients with cone disorders undergoing gene therapy to improve L/M-cone function.
研究不足
The study was limited by the current system's delay in retinal tracking and stimulation, which could result in errors between intended and actual retinal locations to be stimulated, especially in unstable eyes. The range of retinal illuminance tested was also limited to a lower range in human subjects.
1:Experimental Design and Method Selection:
The study involved modifying the Nidek MP1 microperimeter to introduce light from an external projector for high-luminance chromatic stimulation under precise spatiotemporal control.
2:Sample Selection and Data Sources:
Human subjects with retinal degeneration (n = 5) and healthy vision (n = 5) participated.
3:List of Experimental Equipment and Materials:
Modified MP1 microperimeter, external projector (DLP Lightcrafter with DLP3000 micromirror array), optical relay assembly, high-speed video system, calibrated radiometer.
4:Experimental Procedures and Operational Workflow:
The modified MP1 was used to present stimuli with varied sizes, colors, and patterns over a large range of luminance. Retinal tracking performance was evaluated, and spatial resolution was measured with achromatic and chromatic grating/background combinations.
5:Data Analysis Methods:
Data were analyzed to evaluate the spatial resolving properties of the rod, L/M-cone, and S-cone systems.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容